HCW Biologics Inc. (HCWB)
NASDAQ: HCWB · Real-Time Price · USD
7.54
+0.14 (1.89%)
Apr 29, 2025, 4:00 PM EDT - Market closed
HCW Biologics Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for HCW Biologics.
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for HCW Biologics.
Recommendation Trends
Rating | Jan '23 | Feb '23 | Mar '23 | Apr '23 | May '23 | Jun '23 |
---|---|---|---|---|---|---|
Strong Buy | 3 | 3 | 2 | 2 | 2 | 0 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 3 | 3 | 2 | 2 | 2 | 0 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
EF Hutton | EF Hutton | Strong Buy Initiates $360 | Strong Buy | Initiates | $360 | +4,674.54% | Jun 1, 2023 |
EF Hutton | EF Hutton | Strong Buy Reiterates $360 | Strong Buy | Reiterates | $360 | +4,674.54% | Apr 19, 2023 |
EF Hutton | EF Hutton | Strong Buy Reiterates $360 | Strong Buy | Reiterates | $360 | +4,674.54% | Mar 30, 2023 |
EF Hutton | EF Hutton | Strong Buy Reiterates $360 | Strong Buy | Reiterates | $360 | +4,674.54% | Mar 23, 2023 |
JonesTrading | JonesTrading | Strong Buy Initiates $320 | Strong Buy | Initiates | $320 | +4,144.03% | Nov 8, 2022 |
Financial Forecast
Revenue This Year
n/a
from 2.57M
Revenue Next Year
n/a
EPS This Year
-22.44
from -30.96
EPS Next Year
-22.03
from -22.44
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | n/a | n/a | n/a | ||
Avg | n/a | n/a | n/a | ||
Low | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
EPS Forecast
EPS | 2025 | 2026 | 2027 |
---|---|---|---|
High | -23.10 | -22.68 | -24.78 |
Avg | -22.44 | -22.03 | -24.07 |
Low | -21.56 | -21.17 | -23.13 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.